Design Therapeutics (DSGN) Invested Capital (2020 - 2021)
Design Therapeutics' Invested Capital history spans 2 years, with the latest figure at $391.6 million for Q3 2021.
- For Q3 2021, Invested Capital rose 5065.31% year-over-year to $391.6 million; the TTM value through Sep 2021 reached $391.6 million, up 5065.31%, while the annual FY2020 figure was -$11.3 million, N/A changed from the prior year.
- Invested Capital for Q3 2021 was $391.6 million at Design Therapeutics, down from $401.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $408.0 million in Q1 2021 and bottomed at -$11.3 million in Q4 2020.